Abstract
CEL-IV is a C-type lectin isolated from a sea cucumber, Cucumaria echinata. This lectin is composed of four identical C-type carbohydrate-recognition domains (CRDs). X-ray crystallographic analysis of CEL-IV revealed that its tetrameric structure was stabilized by multiple interchain disulfide bonds among the subunits. Although CEL-IV has the EPN motif in its carbohydrate-binding sites, which is known to be characteristic of mannose binding C-type CRDs, it showed preferential binding of galactose and N-acetylgalactosamine. Structural analyses of CEL-IV-melibiose and CEL-IV-raffinose complexes revealed that their galactose residues were recognized in an inverted orientation compared with mannose binding C-type CRDs containing the EPN motif, by the aid of a stacking interaction with the side chain of Trp-79. Changes in the environment of Trp-79 induced by binding to galactose were detected by changes in the intrinsic fluorescence and UV absorption spectra of WT CEL-IV and its site-directed mutants. The binding specificity of CEL-IV toward complex oligosaccharides was analyzed by frontal affinity chromatography using various pyridylamino sugars, and the results indicate preferential binding to oligosaccharides containing Galβ1–3/4(Fucα1–3/4)GlcNAc structures. These findings suggest that the specificity for oligosaccharides may be largely affected by interactions with amino acid residues in the binding site other than those determining the monosaccharide specificity.
Keywords: Calcium-binding proteins, Carbohydrate-binding Protein, Fluorescence, Galactose, Innate Immunity, Lectin, Oligosaccharide, X-ray Crystallography
Introduction
Animal lectins play important roles in various molecular and cellular recognition processes (1). They have been categorized into several families. Among these families, C-type lectins, which recognize carbohydrates depending on the presence of Ca2+ ions, are widely distributed in various organisms and contain C-type carbohydrate-recognition domains (CRDs)3 that function as carbohydrate binding modules in cooperation with other distinct domains (2, 3). C-type lectins are known to play important roles in immunity in vertebrates, but they also appear to function in self-defense systems in invertebrates (4).
We have been investigating three Ca2+-lectins, CEL-I, -III, and -IV, from a sea cucumber Cucumaria echinata. Although CEL-I and CEL-IV belong to the C-type lectins, CEL-III is a unique ricin-type (R-type) lectin that has strong hemolytic and cytotoxic activities. CEL-III is composed of a single polypeptide chain with two CRDs (domains 1 and 2) and one oligomerization domain (domain 3). Although domains 1 and 2 adopt a β-trefoil-fold that is similar to the B-chain of the toxic lectin ricin from the castor bean, they recognize specific carbohydrates via Ca2+ ions in carbohydrate-binding sites in a similar manner to the C-type CRDs (5). After binding to cell surface carbohydrates, CEL-III forms ion-permeable pores by oligomerization through domain 3 in the membrane.
On the other hand, CEL-I and CEL-IV are composed of two and four C-type CRDs, respectively, that are linked by interchain disulfide bonds. The crystal structure of CEL-I (6) revealed that its extremely high specificity for GalNAc (1000-fold higher than that for galactose) was caused by multiple interactions of the acetamido group of GalNAc with several amino acid residues surrounding it. Although CEL-I has no pore-forming activity, unlike CEL-III, it shows cytotoxic activity, especially toward HeLa, MDCK, and XC cells (7). In addition, CEL-I was found to induce the secretion of various cytokines, such as TNF-α and granulocyte colony-stimulating factor, from macrophage cell line RAW264.7 cells (8). Because these effects of CEL-I on cells are at least partly inhibited by the addition of GalNAc, binding of CEL-I to GalNAc-containing carbohydrate chains on the cells seems to be involved in these activities.
The other C-type lectin from C. echinata is CEL-IV, which is a homotetramer of C-type CRDs. This lectin shows Gal/GalNAc-specificity, especially for α-galactosides, whereas CEL-I and CEL-III show higher specificity for β-galactosides (9). In general, C-type CRDs contain carbohydrate recognition motifs composed of three amino acid residues, Gln-Pro-Asp (QPD) or Glu-Pro-Asn (EPN), which are considered to determine their galactose or mannose specificities, respectively (10). In fact, CEL-I has a QPD motif in its carbohydrate-binding site (residues 101–103) in accordance with its Gal/GalNAc specificity. On the other hand, CEL-IV has an EPN motif (residues 113–115) but shows galactose specificity. Similar discrepancies concerning the carbohydrate recognition motif and specificity have been observed in the case of the tunicate lectin TC14 (11), which contains a Glu-Pro-Ser (EPS) motif, similar to EPN, but recognizes galactose residues.
In the present study we determined the crystal structures of CEL-IV and its complexes with two α-galactoside-containing carbohydrates, melibiose and raffinose. The results indicate that CEL-IV recognizes galactose residues in a very different orientation compared with CEL-I with the aid of a stacking interaction with a tryptophan residue. The results further reveal that CEL-IV has higher specificity for l-fucose-containing oligosaccharide structures such as Galβ1–3/4(Fucα1-3/4)GlcNAc.
EXPERIMENTAL PROCEDURES
Purification of Native CEL-IV
CEL-IV was purified from C. echinata by affinity chromatography using carbohydrate-immobilized columns essentially as reported previously (9). However, in this study, we used a column with raffinose (Galα1–6Glcα1–2βFru) as an immobilized carbohydrate for the initial separation of CEL-IV because this lectin shows relatively a high binding specificity for α-galactoside-containing carbohydrates. A raffinose-Cellulofine column was prepared immobilizing raffinose to Cellulofine gel (Seikagaku Kogyo) using the cross-linking reagent divinyl sulfone (12). The crude extract from C. echinata was applied to the raffinose-Cellulofine column in TBS (10 mm Tris-HCl (pH 7.5), 0.15 m NaCl) containing 10 mm CaCl2, and the adsorbed proteins (mostly CEL-IV) were eluted with 20 mm EDTA in TBS. The protein was further purified by gel filtration on a Sephacryl S-200 column (2.5 × 60 cm; GE Healthcare) in TBS.
Crystallization and Data Collection
Crystallization of CEL-IV was carried out by the sitting-drop vapor diffusion method. The protein solution (10 mg/ml, 2–4 μl) in TBS containing CaCl2 was mixed with the same volume of reservoir solution (0.1 m HEPES (pH 7.5), 4.3 m NaCl) and subjected to sitting-drop vapor diffusion at 20 °C. X-ray data collection was performed on beamlines BL6A, NW12, and BL-17A at the High Energy Acceleration Research Organization (Tsukuba, Japan). Diffraction images were indexed and integrated using the program HKL2000 (13) and processed using the CCP4 programs Scala and Truncate (14). The data collection statistics are summarized in Table 1.
TABLE 1.
Data collection and refinement statistics
The values in parentheses are for the highest resolution shell.
| Native | CEL-IV-melibiose complex | CEL-IV-raffinose complex | |
|---|---|---|---|
| Data collection | |||
| X-ray source | Photon factory, BL6A | Photon factory, NW12 | Photon factory, BL17A |
| Wavelength (Å) | 0.978 | 1.000 | 1.000 |
| Resolution (Å) | 47.9-3.00 (3.16-3.00) | 41.9-2.50 (2.59-2.50) | 102-1.65 (1.71-1.65) |
| Space group | P65 | P21 | P21 |
| Unit cell (Å) | a = b = 86.07, c = 375.29 | a = 43.99, b = 78.50, c = 102.90 | a = 41.81, b = 78.16, c = 102.88 |
| α = β = 90.00°, γ = 120.00° | α = γ = 90.00°, β = 98.41° | α = γ = 90.00°, β = 96.82° | |
| I/σ(I) | 29.4 (8.6) | 30.2 (7.0) | 29.4 (2.9) |
| Redundancy | 11.4 (11.1) | 3.5 (3.3) | 3.6 (3.3) |
| Completeness (%) | 99.9 (99.5) | 95.6 (92.4) | 95.0 (85.5) |
| Rmerge | 0.077 (0.298) | 0.109 (0.275) | 0.049 (0.336) |
| Total reflections | 359264 | 79693 | 74625 |
| Unique reflections | 31417 | 22552 | 266904 |
| Refinement statistics | |||
| Resolution (Å) | 43.0-3.0 | 38.1-2.5 | 40.2-1.65 |
| Rwork (%) | 19.6 | 22.9 | 16.5 |
| Rfree (%) | 21.5 | 27.9 | 20.3 |
| Model statistics | |||
| Root mean square deviation | |||
| Bond length (Å) | 0.024 | 0.016 | 0.015 |
| Bond angles (deg) | 2.129 | 1.737 | 1.644 |
Structure Determination and Refinement
The crystal structure of CEL-IV was solved by the molecular replacement method using the C-type lectin CEL-I (Protein Data Bank code 1WMY) (6) as a search model. Molecular replacement was performed using the program Phaser (15). The model was refined using the program Refmac (16) from the CCP4 suite. Manual fitting of the model was carried out using the program Coot (17). The quality of the final model was checked using a Ramachandran plot, and the model geometry was analyzed with the program Procheck (18). The refinement statistics are summarized in Table 1. The figures for the protein models were drawn using the program PyMOL (19). The atomic coordinates and structural factors of the native CEL-IV (code 3ALS) and CEL-IV complexed with melibiose (code 3ALT) and raffinose (code 3ALU) have been deposited in the Protein Data Bank.
Expression of Recombinant CEL-IV
The genes for site-directed mutants of CEL-IV (W79Y and W79H) were constructed by PCR with corresponding 30-bp primers containing the mutation site using a plasmid containing wild-type recombinant CEL-IV (20). The amplified DNA fragments were cloned into Escherichia coli JM109 using the pGEM-T vector (Promega), and the nucleotide sequences were confirmed by DNA sequencing. The inserted genes were digested with NdeI and BamHI and then ligated with the pET-3a vector (Novagen) that had been predigested with the same enzymes. The resulting plasmids containing recombinant CEL-IV genes were used for transformation of E. coli BL21(DE3)pLysS (Novagen). Induction of protein expression was carried out with 1 mm isopropylthiogalactoside, and the cells were incubated for an additional 5 h at 37 °C. The expressed proteins were obtained in inclusion bodies after disruption of the cells by sonication. The inclusion bodies were partially solubilized in 20 mm Tris-HCl buffer (pH 8.5) containing 2 m urea for 30 min at 4 °C. After dialysis against TBS containing 10 mm CaCl2, the solubilized proteins were applied to a raffinose-Cellulofine column equilibrated with the same buffer. The adsorbed proteins were eluted with 20 mm EDTA in TBS and purified by gel filtration on a Sephacryl S-200 column.
Fluorescence Measurements
Fluorescence spectra of the proteins were measured at 25 °C in TBS containing 10 mm CaCl2 using an F-3010 fluorescence spectrophotometer (Hitachi), with excitation at 290 nm to avoid any influence of the fluorescence of tyrosine residues. The effects of the addition of carbohydrates were measured by titrating a carbohydrate solution containing the same concentration of the protein.
UV Absorption Spectra
UV absorption spectra of the proteins were measured at 25 °C in TBS containing 10 mm CaCl2 in a U-2000 spectrophotometer (Hitachi). The changes upon binding of carbohydrates to the proteins were recorded in their difference spectra, which were created by subtracting the spectra of the protein from the spectra of the protein/carbohydrate mixture by placing the solutions in the reference and sample cells, respectively.
Frontal Affinity Chromatography
Frontal affinity chromatography was performed using an automated system as previously described (21, 22) to examine the affinity of CEL-IV for various oligosaccharides. Briefly, CEL-I, CEL-III, and CEL-IV were immobilized to N-hydroxysuccinimide-activated Sepharose 4B Fast Flow (GE Healthcare). Pyridylamino (PA)-oligosaccharides were applied to the lectin-immobilized columns (2.0 × 10 mm, 31.4-μl column volume) in 10 mm Tris-HCl (pH 7.4) containing 0.14 m NaCl and 10 mm CaCl2 and eluted with a flow rate of 0.125 ml/min at 25 °C. The elution of the PA oligosaccharides was monitored by the fluorescence at 380 nm after excitation at 310 nm. The affinities of the PA-oligosaccharides were evaluated by the retardation of the front of their elution using the equation Ka = (V − V0)/Bt, where Ka is the association constant, (V − V0) is the retardation of the elution volume, and Bt is the effective ligand content, which is dependent on the amount of immobilized lectin on the column.
In the case of CEL-I, the Ka was able to be calculated using a Bt value estimated from the concentration dependence of the binding of p-nitrophenyl-α-d-GalNAc as a standard labeled saccharide. However, because of the lack of suitable standard saccharides, the affinities of the PA-oligosaccharides for binding to CEL-III and CEL-IV were only expressed as (V − V0) values.
RESULTS AND DISCUSSION
Crystallization and Structure Determination of CEL-IV
Crystallization of CEL-IV was carried out by the sitting-drop vapor diffusion method at 20 °C using a reservoir solution composed of 0.1 m HEPES (pH 7.5) and 4.3 m NaCl. Although native CEL-IV formed crystals very rapidly, the crystals diffracted X-rays with relatively poor resolution (3.0 Å or lower) using synchrotron radiation. This may be partly because of their high solvent content (∼80%). On the other hand, CEL-IV-melibiose and CEL-IV-raffinose complex crystals gave higher resolutions (2.5 and 1.65 Å, respectively). Therefore, the crystal structures of these complexes were able to be solved by the molecular replacement method using the structural data of the CRD of the other C. echinata lectin CEL-I (6) as a search model. After initial phasing, four protomers of CEL-IV were placed to construct a tetrameric CEL-IV molecule. In each protomer one Ca2+ ion was found in the long loop region (3), which constitutes the carbohydrate-binding sites of many C-type CRDs. Although several C-type CRDs contain more than one Ca2+ ion, CEL-IV has only one Ca2+ ion. In the CEL-IV-melibiose and CEL-IV-raffinose complex crystals, electron densities of the bound carbohydrates were observed near this Ca2+ ion. Therefore, the models of these carbohydrates were fitted with electron density maps, and further refinements were performed. The data collection and refinement statistics are shown in Table 1.
Overall Structure of CEL-IV
Fig. 1 shows the overall structure of the CEL-IV-raffinose complex. As shown in the figure, CEL-IV consists of four subunits that are each composed of a C-type CRD. In many CRDs, two intrachain disulfide bonds (C1-C4 and C2-C3 in Fig. 2) are widely conserved (3). However, CEL-IV lacks a C2-C3 disulfide bond. This is also the case for CEL-I, suggesting that this disulfide bond is not necessarily required to maintain the CRD-fold. CEL-I and CEL-IV contain additional disulfide bonds at C0-C0′, which is characteristic of long-form CRDs (3). In the tetrameric structure of CEL-IV, the four subunits are further held together by interchain disulfide bonds among Cys-1, Cys-41, and Cys-151 (Fig. 1B). Dimer units of the subunits (A-C and B-D pairs) are linked by two disulfide bonds between Cys-41 and Cys-151, and these pairs are further linked by disulfide bonds formed by the N-terminal Cys-1 residues between the A-D and B-C pairs. Although these Cys-1–Cys-1 disulfide bonds were confirmed in the electron density map of the CEL-IV-raffinose complex (Fig. 1C), they were not clearly seen in the maps of the native CEL-IV and CEL-IV-melibiose complex. This suggests that the Cys-1-Cys-1 disulfide bonds are rather flexible and not fixed at particular positions between the subunits. The quaternary structure of CEL-IV is further stabilized in the A-B and C-D pairs through noncovalent interactions between the loops of residues 38–48 (Fig. 2, IP-1 region) and the C-terminal residues 152–157. These regions correspond to additional sequences compared with other CRDs (Fig. 2). There is another insertion (IP-2; residues 70–78) in CEL-IV. This region has a role to place Trp-79 in an appropriate position so that it can interact with the hydrophobic face of a galactose residue, as described below. A bound carbohydrate molecule was seen in each subunit in the complex crystals with raffinose and melibiose. These molecules are recognized through coordinate bonds with Ca2+ ions as well as hydrogen bond networks with nearby amino acid residues. As shown in Fig. 1A, the four carbohydrate-binding sites of the CEL-IV tetramer are oriented apart from one another. Because one of the likely functions of invertebrate lectins is to aggregate foreign microorganisms by binding to their surface carbohydrates, thereby neutralizing and opsonizing them for phagocytosis, such orientations of the binding sites may be preferable. Some of the dimeric C-type lectins from invertebrates, including CEL-I, are also known to have quaternary structures with the carbohydrate-binding sites oriented in opposite directions (23).
FIGURE 1.
Overall structure of the CEL-IV-raffinose complex. A, ribbon model of the homotetrameric structure is shown. The four identical polypeptides (subunits) are indicated in different colors. The side chains of cysteine residues are shown as red sticks. One raffinose molecule (stick model) is bound to each subunit. B, positions of the interchain disulfide bonds between the four subunits of CEL-IV are shown. C, disulfide bonds link the N termini of the subunits.
FIGURE 2.
Comparison of the amino acid sequences of CEL-IV (40), CEL-I (41), tunicate lectin (TC14) (42), and mouse mannose-binding lectin MBL (MBP-A) (43). The cysteine residues involved in disulfide bonds are enclosed in boxes and are designated C0, C0′, and C1-C4 according to a previous report (3). The EPN, QPD, and EPS sequences are also enclosed in a box. The residues coordinating the Ca2+ ion are shaded. The residues forming hydrogen bonds with the galactose residue and stabilizing the binding of carbohydrates through a stacking interaction are shown in red and blue, respectively. The insertion peptides characteristic of CEL-IV are designated IP-1 and IP-2.
Although the fold of the CEL-IV protomer resembles the other C-type CRDs, as representatively shown for C. echinata lectin CEL-I (6), tunicate (Polyandrocarpa misakiensis) lectin TC14 (11), and rat mannose-binding lectin MBL (MBP-A) (24) (Fig. 3), CEL-IV has two extra loops that correspond to the IP-1 and IP-2 regions. These loops play important roles in the formation of the tetrameric structure and carbohydrate-binding site as mentioned above. Although other C-type CRDs contain two or three Ca2+ ions, only one Ca2+ ion was found in each protomer of CEL-IV. This Ca2+ ion corresponds to the Ca-2 position in other CRDs (3) and makes direct interactions with the OH groups of bound carbohydrates.
FIGURE 3.
Comparison of the main-chain structures of CEL-IV, CEL-I, TC14, and MBL. The α-helices and β-sheets are shown in red and yellow, respectively. The Ca2+ ions are shown as magenta spheres. IP-1 and IP-2 indicate the insertion peptides shown in Fig. 2.
Carbohydrate-binding Site Structure of CEL-IV
Fig. 4 shows the carbohydrate-binding sites of the CEL-IV-raffinose and CEL-IV-melibiose complexes. The bound Ca2+ ion is held by coordinate bonds with the side-chain oxygens of Glu-113, Asn-115, Asn-116, and Asp-136 and the main-chain carbonyl oxygen of Asp-136. The hydroxyl groups at the 3- and 4-positions of the galactose residue of both carbohydrates form coordinate bonds with the Ca2+ ion. In addition, the 3-OH group of the galactose residue forms two hydrogen bonds with the side chains of Glu-113 and Asn-115. This carbohydrate recognition mode basically conforms to those of the other C-type CRDs. On the other hand, there are no hydrogen bonds between the 4-OH group of the galactose residue and other amino acid residues. Instead, the 6-OH group of the galactose residue makes a hydrogen bond with Gln-82. Binding of raffinose and melibiose was further stabilized by a stacking interaction between the hydrophobic face of the galactose residue and the side chain of Trp-79. The acetal oxygens in the rings of the glucose and fructose residues in raffinose also make hydrogen bonds with the NH group of Trp-79 and the OH group of Tyr-129, respectively. On the other hand, in the CEL-IV-melibiose complex, the glucose residue of melibiose forms a hydrogen bond between its 4-OH group and the NH-group of Trp-79, resulting in an inverted orientation compared with the glucose residue in the CEL-IV-raffinose complex.
FIGURE 4.
Carbohydrate binding modes to CEL-IV. A and B, carbohydrate binding modes of raffinose (A) and melibiose (B) to CEL-IV are shown. The coordinate bonds and hydrogen bonds are shown as yellow dotted lines.
Fig. 5 shows a comparison of the carbohydrate binding modes of CEL-IV and CEL-I, TC14, and MBL. The orientation of the galactose residue in melibiose bound to CEL-IV is similar to that of galactose bound to TC14, in which the 3-OH group is hydrogen-bonded with the glutamate and serine residues in the EPS motif (Glu-86—Pro-87—Ser-88). On the other hand, the relative orientations of the bound carbohydrates are inverted by nearly 180° in the case of the CEL-I/GalNAc complex, in which the glutamine and aspartate residues in the QPD motif (Gln-101—Pro-102—Asp-103) recognize the 4-OH group of N-acetylgalactosamine. Because the amide NH group of the side chain of Asn/Gln and the carboxyl group of Asp/Glu act as hydrogen donor and acceptor in hydrogen bonding, respectively, the QPD and EPN motifs are thought to specify the orientation of the hydroxyl groups at the 3- or 4-positions of bound carbohydrates (10, 11). In fact, the relative orientations of the 3-OH group of the galactose residues bound to CEL-IV and TC14 are similar to that of the 4-OH group of methyl α-mannoside bound to MBL containing the EPN motif (Glu-185—Pro-186—Asn-187), which accounts for the galactose recognition via the EPN(S) motif in CEL-IV and TC14. The binding of the galactose residue is also stabilized by a stacking interaction with Trp-79 in CEL-IV and Trp-100 in TC14. Such stabilization of galactose binding by aromatic side chains has been observed in various galactose-recognizing lectins, including the other C. echinata lectin CEL-III (5). In the case of CEL-I, the binding of GalNAc is stabilized by Trp-105 located near the C6 atom of GalNAc. On the other hand, MBL has His-189 at a similar position, which stabilizes the binding of mannose. For MBL and CEL-I, the orientations of the hydroxyl groups at the 3-positions of mannose and GalNAc are specified by hydrogen bonds with Glu-193/Asn-205 and Glu-109/Asn-123, respectively. Galactose bound to TC14 forms hydrogen bonds between its 4-OH group and Asp-107 as well as a water molecule (not shown in Fig. 5) in the binding site. In contrast, the 4-OH group of galactose bound to CEL-IV does not form any hydrogen bonds with amino acid residues. However, the hydrogen bond between the 6-OH group and Gln-82 appears to stabilize the binding of the galactose residue in addition to the stacking interaction with Trp-79.
FIGURE 5.
Residues involved in the binding of specific carbohydrates to CEL-IV, CEL-I, TC14, and MBL. The EPN, EPS, and QPD sequences are shown in red.
Although Trp-79 in CEL-IV plays a similar role to Trp-100 in TC14 for galactose binding, their positions in the amino acid sequence are not equivalent, as shown in Fig. 2. This suggests that they are not closely related in the evolutionary lineage of C-type lectins. In fact, the sequence identity between CEL-IV and TC14 is relatively low (20.7%). Fig. 6 illustrates the difference in the positions of these residues. Trp-79 of CEL-IV is located at the end of the IP-2 loop, whereas Trp-100 of TC14 is at the end of β-strand β2. These facts suggest that the similarity in the galactose recognition modes of CEL-IV and TC14 is an example of convergent evolution. Other lectins with the EPN motif showing galactose specificity are also present in some marine organisms such as AJL-2 from the skin mucus of the Japanese eel (Anguilla japonica) (25) and the eggs of the shishamo smelt (Spirinchus lanceolatus) (26). In these cases, tryptophan residues are not conserved at the positions corresponding to Trp-79 in CEL-I and Trp-100 in TC14.
FIGURE 6.
Positions of the tryptophan residues involved in stacking interactions with the galactose residues in CEL-IV and TC14. The tryptophan residues and IP-2 region (CEL-IV) are shown in red.
Interactions between CEL-IV and Specific Carbohydrates
Because Trp-79 makes a stacking interaction with the hydrophobic face of the galactose residue, it was examined using the intrinsic fluorescence changes, which mostly arise from tryptophan residues in the protein. As shown in Fig. 7A, when melibiose was added to the CEL-IV solution the maximum fluorescence of CEL-IV shifted to a shorter wavelength, and its intensity increased. These observations suggested that binding of melibiose changed the environment of the tryptophan residue(s) in the protein. Binding of a specific carbohydrate was also detected by changes in the UV absorption spectra of CEL-IV. As shown in Fig. 8A, when melibiose was added to the protein solution, increases in the positive maxima at 293 and 286 nm were observed, which arose from a red shift of the UV-absorption spectra. Along with the fluorescence spectral changes, these findings suggest that the environment of the tryptophan residue(s), possibly Trp-79, became more nonpolar (27, 28). These spectral changes increased as the concentration of the carbohydrate increased (Fig. 9) and produced saturation curves. To clarify whether such spectral changes are caused by Trp-79, site-directed mutants of CEL-IV in which Trp-79 was replaced by tyrosine (W79Y) or histidine (W79H) residues were prepared, and their fluorescence and UV spectra were examined. As shown in Figs. 7, B and C, and 8B, the W79Y and W79H mutants showed little changes in their fluorescence spectra when melibiose was added, whereas W79Y exhibited a positive maximum at 289 nm in the UV difference spectra, which was probably caused by an interaction with Tyr-79, judging from the wavelength (28, 29). These results strongly suggest that the changes in the fluorescence and UV absorption spectra of CEL-IV were caused by an interaction between melibiose and Trp-79 located in the carbohydrate-binding site. Because the fluorescence of the tyrosine residue was very weak, binding of melibiose to W79Y was not fully observed (Fig. 7B). Association constants for the binding of the carbohydrates to WT CEL-IV and W79Y were calculated from the fluorescence and UV absorption changes. As shown in Fig. 9, the changes were well approximated to the curves based on the equations ΔF = ΔFmax[S]/(Kd + [S]) or ΔA = ΔAmax[S]/(Kd + [S]), where Kd is the dissociation constant, [S] is the carbohydrate concentration, ΔFmax is the maximal difference in the fluorescence, and ΔAmax is the maximal difference of the UV absorption. The obtained Ka (=1/Kd) values are listed in Table 2. The association constants calculated from the changes in the fluorescence and UV absorption spectra showed relatively good agreement for binding of both GalNAc and melibiose to WT CEL-IV, confirming that they reflect the changes in the identical tryptophan residue, Trp-79. Furthermore, the UV difference spectra of W79Y with positive peaks at 289 nm indicate that the tyrosine residue can substitute for Trp-79, but with lower affinity, suggesting the importance of the more hydrophobic nature of tryptophan compared with that of tyrosine. In addition, the bulkiness of tryptophan may be advantageous in carbohydrate binding by eliminating water molecules from the carbohydrate-binding site. The importance of a tryptophan residue in galactose binding was also observed in the case of galactose binding MBL (MBP-A) mutants, in which the EPN motif had been replaced by the QPD motif. In these mutants, an additionally introduced tryptophan residue instead of His-189 (see MBL/α-Me-Man in Fig. 5) effectively enhanced the galactose binding, whereas phenylalanine at the same position had less effects (30). Regarding the CEL-IV mutants, the carbohydrate binding ability of W79H appeared to be even weaker when its amount of binding to the affinity column (GalNAc-Cellulofine) was compared with that of W79Y (data not shown). It is likely that the smaller and more hydrophilic nature of the histidine side chain is not suitable for providing sufficient force to stabilize galactose binding.
FIGURE 7.
Fluorescence changes of CEL-IV and its mutants upon binding of melibiose. A–F, shown are fluorescence spectra in the absence (solid lines) and presence (dashed lines) of melibiose (A–C) and the difference spectra of WT CEL-IV (A and D), W79Y (B and E), and W79H (C and F). The excitation wavelength was 290 nm. a.u., arbitrary units.
FIGURE 8.
UV difference spectra of WT CEL-IV and its W79Y mutant induced by binding of melibiose. A, WT. B, W79Y mutant.
FIGURE 9.
Variations of the changes in the fluorescence and UV difference spectra of CEL-IV upon binding of melibiose. The changes in the fluorescence intensity at 320 nm and absorbance at 293 nm are plotted against the melibiose concentrations. The solid lines show the theoretical curves.
TABLE 2.
Association constants for the binding of specific carbohydrates to recombinant CEL-IV obtained from the changes in the fluorescence and UV absorption spectra
ND, not determined.
| Recombinant CEL-IV | Association constant |
|||
|---|---|---|---|---|
| GalNAc |
Melibiose |
|||
| Fluorescence | UV absorption | Fluorescence | UV absorption | |
| ×103m−1 | ||||
| WT | 6.4 | 5.3 | 0.84 | 0.33 |
| W78Y | ND | 0.26 | ND | 0.083 |
Oligosaccharide Specificity of CEL-IV Analyzed by Frontal Affinity Chromatography
Fig. 10 shows the carbohydrate binding specificities of CEL-IV in comparison with those of CEL-I and CEL-III for various oligosaccharides analyzed by frontal affinity chromatography. In these analyses, fluorescently labeled PA oligosaccharides (Fig. 11) were applied to columns containing the immobilized lectins, and the retardation of their elution (V − V0) caused by interactions between the oligosaccharides and the lectins were measured to determine their affinities. As shown in Fig. 10, CEL-IV exhibited relatively high affinity for oligosaccharide numbers 731 (Fucα1–2Galβ1–3(Fucα1–4)GlcNAcβ1–3Galβ1–4Glc) and 910 (Fucα1–2Galβ1–4(Fucα1–3)GlcNAc). Oligosaccharide numbers 419, 420, 726, 727, and 730 also showed appreciable affinities. These oligosaccharides commonly contain Galβ1–3/4(Fucα1–3/4)GlcNAc structures. Therefore, it seems reasonable to assume that CEL-IV preferentially binds to oligosaccharides with these structures. Although oligosaccharide numbers 721, which also has this structure, showed no affinity, this may be ascribed to the additional GalNAc residue at the nonreducing end linked to the Gal residue by an α1–3 linkage. On the other hand, the other C-type lectin CEL-I exhibited considerably different preferences for binding. This lectin strongly bound to oligosaccharide numbers 702, 708, 716, and 717, which contain GalNAcβ1–3/4 structures, and weakly bound to oligosaccharide numbers 719, 720, and 721, which contain GalNAcα1–3 linkages. These observations are consistent with the results obtained from hemagglutination assays (9) in which GalNAc showed the highest hemagglutination inhibition and also revealed a preference for β-GalNAc. CEL-III is a unique R-type lectin with a β-trefoil fold (31, 32) containing Ca2+ ions in the carbohydrate binding domains. This lectin showed the highest affinity for oligosaccharide number 729 and moderately high affinity for several N-linked glycans. These oligosaccharides contain Galβ1–3/4GlcNAc structures. These findings show that the oligosaccharide specificities of C. echinata lectins are apparently different, although they are Gal/GalNAc-specific in terms of monosaccharide specificities. Such differences in the oligosaccharide specificities may be related to the diversity of their target molecules.
FIGURE 10.
Affinities of PA oligosaccharides for CEL-IV assessed by frontal affinity chromatography. The analysis was performed using 93 oligosaccharides (22). The affinities of the oligosaccharides are represented by the retardation of their elution (V − V0) values. The oligosaccharides are indicated by numbers that correspond to those shown in Fig. 11 and are the same as in the previous report (22). In the case of CEL-I, the affinities are also represented as association constant (Ka) values on the right scale. Oligosaccharides with (V − V0) values of <5 μl (CEL-I) or <3 μl (CEL-III and CEL-IV) were classified as showing no interactions.
FIGURE 11.
Structures of the PA oligosaccharides used in the frontal affinity chromatography. The images were drawn using the website GlycomeDB.
Diversity of Carbohydrate Recognition by C-type Lectins
Although the exact functions and targets of the C-type lectins, CEL-I and CEL-IV, in C. echinata are still unclear, it is very likely that these lectins play defensive roles against invading microorganisms or predators. In addition to the role as opsonins for phagocytosis, it also seems possible that they may directly act as toxic substances, as does CEL-III. It is well known that various lectins are present in the seeds of plants and that some of them exhibit strong toxicity. For example, ricin from the castor bean (Ricinus communis) and abrin from Abrus precatorius (33) exert strong toxicities via enzymatic activities as N-glycosidases that cleave off a particular adenine base in the 28 S rRNA of eukaryotic cells (34). On the other hand, even binding of some lectins to carbohydrate chains on the cell surface often causes damage to cell functions, leading to various biological consequences such as apoptosis (35–37). For self-defense of animals via chemical substances, such as toxins, recognition of a wide variety of carbohydrates on foreign cells may be advantageous to exert their biological effects.
Recently, regenerating gene family proteins RegIII and RegIV, which adopt a C-type lectin-like fold, were found to bind to carbohydrates with EPN or DPQ motifs located in a distinct region from the Ca2+-binding sites of canonical C-type lectins (38, 39). They recognize peptidoglycan (RegIII) or mannan/heparin (RegIV) in a Ca2+-independent manner and exert bactericidal activity. Although the detailed structural data for the binding mechanisms of these proteins remain to be elucidated, these findings suggest that such motifs of three consecutive amino acids (EPN and DPQ), composed of hydrogen donor and acceptor residues flanking a proline residue, could play versatile roles in the carbohydrate recognition of C-type lectins even without bound Ca2+. These Reg family proteins recognize polysaccharides, probably through interactions with relatively large portions of their carbohydrate-binding sites. In the case of RegIV, it has been suggested that different conformers around the binding site would enable a wide range of binding functions with the same molecule (39). For recognition of oligosaccharides or polysaccharides, multiple interactions with sites other than the specificity-determining tripeptide motifs may be very important. As shown in Fig. 4 the orientation of the galactose moiety bound to CEL-IV via the EPN motif appears to lead favorable binding to α-galactoside-containing oligosaccharides through increased interactions between carbohydrates and the protein, which may also be associated with the unexpected binding specificity for oligosaccharides containing α-fucoside. The versatile roles of the C-type CRDs in the recognition of various target carbohydrates seem to be based on their potential to utilize combinations of the limited binding motifs and structural diversity of the long loop regions, supported by the stable core structure of the common fold composed of α-helices and β-sheets.
Acknowledgment
We are grateful to Junko Kominami for technical assistance in frontal affinity chromatography analysis.
This work was conducted under the Cooperative Research Program of Institute for Protein Research, Osaka University and was supported by Grant-in-aid for Scientific Research 20580100 from the Japan Society for the Promotion of Science.
The atomic coordinates and structure factors (codes 3ALS, 3ALT, and 3ALU) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
- CRD
- carbohydrate-recognition domain
- PA
- pyridylamino
- MBL
- mannose-binding lectin.
REFERENCES
- 1. Kilpatrick D. C. (2002) Biochim. Biophys. Acta 1572, 187–197 [DOI] [PubMed] [Google Scholar]
- 2. Drickamer K. (1999) Curr. Opin. Struct. Biol. 9, 585–590 [DOI] [PubMed] [Google Scholar]
- 3. Zelensky A. N., Gready J. E. (2005) FEBS J. 272, 6179–6217 [DOI] [PubMed] [Google Scholar]
- 4. Liu Y. C., Li F. H., Dong B., Wang B., Luan W., Zhang X. J., Zhang L. S., Xiang J. H. (2007) Mol. Immunol. 44, 598–607 [DOI] [PubMed] [Google Scholar]
- 5. Hatakeyama T., Unno H., Kouzuma Y., Uchida T., Eto S., Hidemura H., Kato N., Yonekura M., Kusunoki M. (2007) J. Biol. Chem. 282, 37826–37835 [DOI] [PubMed] [Google Scholar]
- 6. Sugawara H., Kusunoki M., Kurisu G., Fujimoto T., Aoyagi H., Hatakeyama T. (2004) J. Biol. Chem. 279, 45219–45225 [DOI] [PubMed] [Google Scholar]
- 7. Kuramoto T., Uzuyama H., Hatakeyama T., Tamura T., Nakashima T., Yamaguchi K., Oda T. (2005) J. Biochem. 137, 41–50 [DOI] [PubMed] [Google Scholar]
- 8. Yamanishi T., Yamamoto Y., Hatakeyama T., Yamaguchi K., Oda T. (2007) J. Biochem. 142, 587–595 [DOI] [PubMed] [Google Scholar]
- 9. Hatakeyama T., Kohzaki H., Nagatomo H., Yamasaki N. (1994) J. Biochem. 116, 209–214 [DOI] [PubMed] [Google Scholar]
- 10. Drickamer K. (1992) Nature 360, 183–186 [DOI] [PubMed] [Google Scholar]
- 11. Poget S. F., Legge G. B., Proctor M. R., Butler P. J., Bycroft M., Williams R. L. (1999) J. Mol. Biol. 290, 867–879 [DOI] [PubMed] [Google Scholar]
- 12. Hatakeyama T., Nagatomo H., Yamasaki N. (1995) J. Biol. Chem. 270, 3560–3564 [DOI] [PubMed] [Google Scholar]
- 13. Otwinowski Z., Minor W. (1997) Methods Enzymol. 276, 307–326 [DOI] [PubMed] [Google Scholar]
- 14. Collaborative Computational Project, N4 (1994) Acta Crystallogr. D Biol. Crystallogr. 50, 760–76315299374 [Google Scholar]
- 15. McCoy A. J., Grosse-Kunstleve R. W., Storoni L. C., Read R. J. (2005) Acta Crystallogr. D Biol. Crystallogr. 61, 458–464 [DOI] [PubMed] [Google Scholar]
- 16. Murshudov G. N., Vagin A. A., Dodson E. J. (1997) Acta Crystallogr. D Biol. Crystallogr. 53, 240–255 [DOI] [PubMed] [Google Scholar]
- 17. Emsley P., Cowtan K. (2004) Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 [DOI] [PubMed] [Google Scholar]
- 18. Laskowski R., MacArthur M., Moss D., Thornton J. (1993) J. Appl. Crystallogr. 26, 283–291 [Google Scholar]
- 19. DeLano W. L. (2002) The PyMOL Molecular Graphics System, DeLano Scientific LLC, San Carlos, CA [Google Scholar]
- 20. Hatakeyama T., Hozawa T., Hirotani I., Tsuda N., Kusunoki M., Shiba K. (2006) Biochim. Biophys. Acta 1760, 318–325 [DOI] [PubMed] [Google Scholar]
- 21. Hirabayashi J. (2004) Glycoconj. J. 21, 35–40 [DOI] [PubMed] [Google Scholar]
- 22. Nakamura S., Yagi F., Totani K., Ito Y., Hirabayashi J. (2005) FEBS J. 272, 2784–2799 [DOI] [PubMed] [Google Scholar]
- 23. Gourdine J. P., Cioci G., Miguet L., Unverzagt C., Silva D. V., Varrot A., Gautier C., Smith-Ravin E. J., Imberty A. (2008) J. Biol. Chem. 283, 30112–30120 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Ng K. K., Kolatkar A. R., Park-Snyder S., Feinberg H., Clark D. A., Drickamer K., Weis W. I. (2002) J. Biol. Chem. 277, 16088–16095 [DOI] [PubMed] [Google Scholar]
- 25. Tasumi S., Ohira T., Kawazoe I., Suetake H., Suzuki Y., Aida K. (2002) J. Biol. Chem. 277, 27305–27311 [DOI] [PubMed] [Google Scholar]
- 26. Hosono M., Sugawara S., Ogawa Y., Kohno T., Takayanagi M., Nitta K. (2005) Biochim. Biophys. Acta 1725, 160–173 [DOI] [PubMed] [Google Scholar]
- 27. Cowgill R. W. (1967) Biochim. Biophys. Acta 133, 6–18 [DOI] [PubMed] [Google Scholar]
- 28. Yanari S., Bovey F. A. (1960) J. Biol. Chem. 235, 2818–2826 [PubMed] [Google Scholar]
- 29. Yamasaki N., Hatakeyama T., Funatsu G. (1985) J. Biochem. 98, 1555–1560 [DOI] [PubMed] [Google Scholar]
- 30. Iobst S. T., Drickamer K. (1994) J. Biol. Chem. 269, 15512–15519 [PubMed] [Google Scholar]
- 31. Uchida T., Yamasaki T., Eto S., Sugawara H., Kurisu G., Nakagawa A., Kusunoki M., Hatakeyama T. (2004) J. Biol. Chem. 279, 37133–37141 [DOI] [PubMed] [Google Scholar]
- 32. Hazes B. (1996) Protein Sci. 5, 1490–1501 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Olsnes S. (2004) Toxicon 44, 361–370 [DOI] [PubMed] [Google Scholar]
- 34. Endo Y., Tsurugi K., Yutsudo T., Takeda Y., Ogasawara T., Igarashi K. (1988) Eur. J. Biochem. 171, 45–50 [DOI] [PubMed] [Google Scholar]
- 35. Liu B., Xu X. C., Cheng Y., Huang J., Liu Y. H., Liu Z., Min M. W., Bian H. J., Chen J., Bao J. K. (2008) BMB Rep. 41, 369–375 [DOI] [PubMed] [Google Scholar]
- 36. SundarRaj S., Soni C., Karande A. A. (2009) Mol. Immunol. 46, 3411–3419 [DOI] [PubMed] [Google Scholar]
- 37. Kuroda J., Yamamoto M., Nagoshi H., Kobayashi T., Sasaki N., Shimura Y., Horiike S., Kimura S., Yamauchi A., Hirashima M., Taniwaki M. (2010) Mol. Cancer Res. 8, 994–1001 [DOI] [PubMed] [Google Scholar]
- 38. Lehotzky R. E., Partch C. L., Mukherjee S., Cash H. L., Goldman W. E., Gardner K. H., Hooper L. V. (2010) Proc. Natl. Acad. Sci. U.S.A. 107, 7722–7727 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Ho M. R., Lou Y. C., Wei S. Y., Luo S. C., Lin W. C., Lyu P. C., Chen C. (2010) J. Mol. Biol. 402, 682–695 [DOI] [PubMed] [Google Scholar]
- 40. Hatakeyama T., Ohuchi K., Kuroki M., Yamasaki N. (1995) Biosci. Biotechnol. Biochem. 59, 1314–1317 [DOI] [PubMed] [Google Scholar]
- 41. Hatakeyama T., Matsuo N., Shiba K., Nishinohara S., Yamasaki N., Sugawara H., Aoyagi H. (2002) Biosci. Biotechnol. Biochem. 66, 157–163 [DOI] [PubMed] [Google Scholar]
- 42. Suzuki T., Takagi T., Furukohri T., Kawamura K., Nakauchi M. (1990) J. Biol. Chem. 265, 1274–1281 [PubMed] [Google Scholar]
- 43. Drickamer K., Dordal M. S., Reynolds L. (1986) J. Biol. Chem. 261, 6878–6887 [PubMed] [Google Scholar]












